Chilling new details in Gene Hackman's wife Betsy Arakawa's autopsy revealed
New details surrounding Betsy Arakawa's death have been revealed by her final autopsy results.
The 95-year-old French Connection actor and his wife, Betsy Arakawa, 65, were found dead at their home in Santa Fe, New Mexico, at the end of February.
The usual way they were discovered sparked a police investigation into their deaths.
It was later revealed that Hackman, 95, died of heart disease with advanced Alzheimer's disease listed as a significant contributory factor', while the classical pianist, 65, battled hantavirus – a rare, infectious condition – before her death.
It has now emerged that Arakawa had fluid in her chest, and the vessels supplying blood to her heart and body had mild hardening, as confirmed in an autopsy seen by AP as reported by Fox.
She died from hantavirus pulmonary syndrome, which was transmitted by rodents living around their home.
It was confirmed that she tested negative for COVID-19 and the flu. She also had normal carbon monoxide levels and tested positive for caffeine but negative for alcohol and intoxicating drugs.
This comes just a couple of days after the release of Hackman's final autopsy.
Fox reported that the final autopsy from the Office of the Medical Investigator in New Mexico, has revealed he had further health issues.
As well as a 'history of congestive heart failure' and 'severe chronic hypertensive changes, kidneys', the actor also had a 'bi-ventricular pacemaker' fitted in April 2019.
The documents noted 'neurodegenerative features consistent with Alzheimer's Disease'.
The report read: 'Autopsy showed severe atherosclerotic and hypertensive cardiovascular disease, with placement of coronary artery stents and a bypass graft, as well as a previous aortic valve replacement.
'Remote myocardial infarctions were present involving the left ventricular free wall and the septum, which were significantly large.
'Examination of the brain showed microscopic findings of advanced-stage Alzheimer's disease.'
Police say Hackman likely died on February 18, almost a week after his wife Arakawa is thought to have died on February 11.
On February 9 Arakawa took the dog, who was found deceased in the crate, to the vets for a procedure.
On February 11 Arakawa sent her last email, to her massage therapist at around 11am. In the afternoon, she took a trip to a farmer's market, CVS pharmacy and a pet food shop.
Her car was used to access the gated community after 5pm. She did not have any ongoing communication or activity in the local area after February 11.
On February 12, Arakawa made multiple calls to a health clinic for medical treatment, which she was not able to receive. She also googled health care providers – having previously searched for causes of symptoms she was experiencing.
Gene Hackman's pacemaker detected cardiac activity on February 17, and an abnormal rhythm on February 18, when activity stopped.
Their bodies were discovered on February 26, 15 days after Arakawa was thought to have died, and eight days after Hackman's pacemaker recorded its last heartbeat.
Two weeks ago, the couple was laid to rest in a private funeral with friends and family invited to the event. More Trending
Hackman's three children, Christopher, 65, Elizabeth, 62, and Leslie, 58, from his first marriage to Faye Maltese were all in attendance.
In March, TMZ obtained a copy of Hackman's will, which appeared to show that he left his entire fortune to his partner, and made her the sole beneficiary in 1995.
Although his children were not included, TMZ reported that Hackman's children will 'presumably get his share' as they are his direct living heirs.
Got a story?
If you've got a celebrity story, video or pictures get in touch with the Metro.co.uk entertainment team by emailing us celebtips@metro.co.uk, calling 020 3615 2145 or by visiting our Submit Stuff page – we'd love to hear from you.
MORE: Carrie and Dallas actress Priscilla Pointer dies aged 100
MORE: Christie Brinkley recalls public moment she discovered husband's affair with 'teenager'
MORE: Donald Trump's hatred-fuelled 'obsession' with Taylor Swift intensifies with fresh dig
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Powys County Times
42 minutes ago
- Powys County Times
Gut bacteria changes could be ‘warning sign for worsening Parkinson's symptoms'
Changes in specific bacteria in the mouth and gut of patients with Parkinson's disease could potentially be an early warning sign that symptoms of the condition are getting worse, a study suggests. With the help of artificial intelligence (AI), scientists have linked these shifts to cognitive decline – problems with memory and learning – in people with the disease. They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease. Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues. According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia. Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. 'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage. 'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.' For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples. The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients. The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth. This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers. For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline. Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes. 'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected. 'Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.' Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. 'But our findings suggest they may play an active role in worsening symptoms.' Dr Clasen suggests these markers could one day be used to develop targeted treatments. 'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said. 'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
South Wales Guardian
42 minutes ago
- South Wales Guardian
Gut bacteria changes could be ‘warning sign for worsening Parkinson's symptoms'
With the help of artificial intelligence (AI), scientists have linked these shifts to cognitive decline – problems with memory and learning – in people with the disease. They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease. Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues. According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia. Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. 'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage. 'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.' For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples. The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients. The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth. This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers. For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline. Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes. 'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected. 'Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.' Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. 'But our findings suggest they may play an active role in worsening symptoms.' Dr Clasen suggests these markers could one day be used to develop targeted treatments. 'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said. 'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
Rhyl Journal
43 minutes ago
- Rhyl Journal
Gut bacteria changes could be ‘warning sign for worsening Parkinson's symptoms'
With the help of artificial intelligence (AI), scientists have linked these shifts to cognitive decline – problems with memory and learning – in people with the disease. They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease. Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues. According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia. Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. 'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage. 'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.' For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples. The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients. The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth. This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers. For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline. Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes. 'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected. 'Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.' Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. 'But our findings suggest they may play an active role in worsening symptoms.' Dr Clasen suggests these markers could one day be used to develop targeted treatments. 'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said. 'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
